bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
Khresmoi - new !
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2017: D N O S A J J M A M F J
2016: D

 
  Other news for:
Physicians
 Resources from HONselect
Taking Your Meds? A Digital Pill Can Tell

By Alan Mozes

MONDAY, Dec. 4, 2017 (HealthDay News) -- Pairing medication with an ingestible sensor can help clinicians track how often and when patients actually take their prescription drugs, according to a small new investigational study.

The findings come on the heels of the U.S. Food and Drug Administration's decision last month to approve the first digital pill for use with the antipsychotic drug Abilify, often prescribed to treat schizophrenia, bipolar disorder and depression.

The new research involved just 15 patients, all of whom had been prescribed the opioid pain drug oxycodone (OxyContin) after sustaining a fracture.

However, the study participants were given a special configuration of oxycodone. The pain med was packaged together with a so-called "digital pill." This meant that each time a patient took the pain med, they ingested a gelatin capsule that contained the oxycodone as well as a radiofrequency emitter.

The emitter was automatically activated when the capsule was swallowed. It sent signals to a sticky patch placed on the person's abdomen. That, in turn, conveyed basic pill-taking information to an iPod-sized reader.

The system enabled researchers to track how many pills the 15 patients actually took, rather than the number of pills they'd been given.

On average, the patients took just six pills total -- even though they had been provided a supply of 21 pills, according to the report.

"As an investigational tool, the digital pill provides a direct measure of opioid ingestion and changes in medication-taking behavior," senior author Dr. Edward Boyer said in a news release from Brigham and Women's Hospital in Boston.

"This technology may also make it possible for physicians to monitor adherence, identify escalating opioid use patterns that may suggest the development of tolerance or addiction, and intervene for a specific medical condition or patient population," he added.

Boyer is with the medical toxicology division within the hospital's department of emergency medicine.

Boyer and his colleagues published their findings in the December issue of the journal Anesthesia & Analgesia.

More information

The U.S. Food and Drug Administration has more on digital pills.

SOURCE: Brigham and Women's Hospital, news release, Nov. 20, 2017

Copyright © 2017 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=728841

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Pain
Physicians
Women
Analgesia
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Inicio img Sobre nosotros img Rincón de la prensa img Boletín HON img Mapa del sitio img Política ética img Contactos